Concepedia

Scott W. Baumgartner

SW

12

Publications

2.8K

Citations

12

H-Index

1997

Active since

Affiliations

Amgen (United States)(Current)

University of Colorado Denver

Brigham and Women's Hospital

Hospital for Special Surgery

Mount Sinai Hospital

Scott W. Baumgartner is an author at Amgen (United States) specializing in inflammatory arthritis, inflammation, and immune regulation.

Top concepts

Publications per year

1997–2011

12

Publications

12

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Larry W. Moreland, Scott W. Baumgartner, Michael Schiff et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

, , +19

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

Daniel J. Lovell, Andreas Reiff, Norman T. Ilowite et al. · Arthritis & Rheumatism · 2008 · 317 citations

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

Larry W. Moreland, S. Cohen, Scott W. Baumgartner et al. · PubMed · 2001 · 201 citations

Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.

Phillip J. Mease, Christopher T. Ritchlin, Richard W. Martin et al. · PubMed · 2004 · 156 citations

Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis

Michael E. Weinblatt, Joan M. Bathon, Joel M. Kremer et al. · Arthritis Care & Research · 2010 · 102 citations

Rows per page

1–5 of 12